| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 704869-38-5 | SUN11602 |
≥98% | | 询价 |
| 2 | 613677-28-4 | LASMIDITAN HCl(COL144 HCl,LY573144 HCl) |
≥98% | | 询价 |
| 3 | 439239-90-4 | LASMIDITAN(COL 144,LY 573144) |
≥98% | | 询价 |
| 4 | 1691249-45-2 | Zanubrutinib |
≥98% | | 询价 |
| 5 | 928672-86-0 | Canagliflozin hemihydrate(JNJ 28431754) |
≥98% | | 询价 |
| 6 | 3895-92-9 | Chelerythrine Chloride |
≥98% | | 询价 |
| 7 | 2070014-82-1 | Osimertinib dimesylate |
≥98% | | 询价 |
| 8 | 1421373-66-1 | Osimertinib mesylate |
≥98% | | 询价 |
| 9 | 1698055-85-4 | ARS-1620 |
≥98% | | 询价 |
| 10 | 2097938-73-1 | MBQ-167 |
≥98% | | 询价 |
| 11 | 211555-05-4 | WHI-P97 |
≥98% | | 询价 |
| 12 | 202475-60-3 | JANEX-1 |
≥98% | | 询价 |
| 13 | 1362850-20-1 | Seletalisib |
≥98% | | 询价 |
| 14 | 1354691-97-6 | Leniolisib phosphate |
≥98% | | 询价 |
| 15 | 1354690-24-6 | Leniolisib |
≥98% | | 询价 |
| 16 | 1219739-36-2 | EX-229 |
≥98% | | 询价 |
| 17 | 610318-03-1 | Abequolixron(RGX-104)HCl |
≥98% | | 询价 |
| 18 | 610318-54-2 | Abequolixron(RGX-104) |
≥98% | | 询价 |
| 19 | | GSK2643943A |
≥98% | | 询价 |
| 20 | 119169-78-7 | Epristeride |
≥98% | | 询价 |
| 21 | 13241-28-6 | Chrysophanol-8-O-beta-D-glucopyranoside |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 189290-58-2 | AG-1557 |
≥98% | | 询价 |
| 23 | 1297537-33-7 | ORM-15341 |
≥98% | | 询价 |
| 24 | 872365-14-5 | Fevipiprant |
≥98% | | 询价 |
| 25 | 1190094-64-4 | CP-609754(OSI754,LNK 754) |
≥98% | | 询价 |
| 26 | 1093119-54-0 | MKC3946 |
≥98% | | 询价 |
| 27 | 1802148-05-5 | Brensocatib(AZD7986) |
≥98% | | 询价 |
| 28 | 423145-35-1 | YUM70 |
≥98% | | 询价 |
| 29 | 6100-74-9 | Isoacetovanillone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 606143-52-6 | Selumetinib(AZD-6244 ARRY142886) |
≥98% | | 询价 |
| 31 | 77591-33-4 | Thymosinβ4(human,bovine,horse,rat) |
≥98% | | 询价 |
| 32 | 36451-14-6 | Epitheaflavin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 2206735-75-1 | KRas G12C inhibitor 3 |
≥98% | | 询价 |
| 34 | 2206735-61-5 | KRas G12C inhibitor 2 |
≥98% | | 询价 |
| 35 | 2158297-28-8 | KRas G12C inhibitor 1 |
≥98% | | 询价 |
| 36 | 2206736-07-2 | KRas G12C inhibitor 4 |
≥98% | | 询价 |
| 37 | 1431525-23-3 | BMX-IN-1 |
≥98% | | 询价 |
| 38 | 1346669-54-2 | G-744 |
≥98% | | 询价 |
| 39 | 871266-63-6 | PCI-27483 |
≥98% | | 询价 |
| 40 | 330786-25-9 | PCI-29732 |
≥98% | | 询价 |
| 41 | 1022899-36-0 | PCI-33380 |
≥98% | | 询价 |
| 42 | 944795-06-6 | Lck inhibitor 2 |
≥98% | | 询价 |
| 43 | 1469988-75-7 | QL47 |
≥98% | | 询价 |
| 44 | 2095393-15-8 | Nemtabrutinib(ARQ-531) |
≥98% | | 询价 |
| 45 | 1370466-81-1 | CG-806 |
≥98% | | 询价 |
| 46 | 2095280-64-9 | CHMFL-BTK-01 |
≥98% | | 询价 |
| 47 | 1558036-85-3 | Btk inhibitor 2 |
≥98% | | 询价 |
| 48 | 1412418-47-3 | Btk inhibitor 1 |
≥98% | | 询价 |
| 49 | 852948-13-1 | MB-07811(VK-2809) |
≥98% | | 询价 |
| 50 | 2109805-56-1 | CLK-IN-T3 |
≥98% | | 询价 |
| 51 | 1360053-81-1 | Spebrutinib besylate |
≥98% | | 询价 |
| 52 | 1448189-98-7 | VHL ligand 3 |
≥98% | | 询价 |
| 53 | 1270014-40-8 | BTK IN-1 |
≥98% | | 询价 |
| 54 | 92134-98-0 | Fosphenytoin Sodium(ACC-9653) |
≥98% | | 询价 |
| 55 | 1698024-73-5 | ARS-1323 |
≥98% | | 询价 |
| 56 | 1482500-76-4 | ML-290 |
≥98% | | 询价 |
| 57 | 1550008-55-3 | ML264 |
≥98% | | 询价 |
| 58 | 1422269-30-4 | ML18 |
≥98% | | 询价 |
| 59 | 109376-83-2 | ML-7 |
≥98% | | 询价 |
| 60 | 110448-33-4 | ML-7 HCl |
≥98% | | 询价 |
m.cnreagent.com